News									
								
			NEWS
			
		
	- 
			
				.jpg) R&D R&DCore patents for albumin-free, serum-free HSC expansion method allowed in Japan
- 
			
				 news newsJoining the 2025 AABB/Cord Blood Connect in San Diego
- 
			
				financingCelaid Therapeutics Raises JPY 1.055 Billion (USD 7.2 Million) in the First Close of its Series B Financing
- 
			
				 HR HRCareer Opportunities
- 
			
				 news newsExhibit at BioJapan 2025
- 
			
				 news newsParticipate in the 2025 Cell & Gene Meeting on the Mesa
- 
			
				 news newsExhibiting at Global Startup EXPO 2025
- 
			
				.jpg) R&D R&DSuccessful Completion of AMED Stage-Gate Evaluation for CLD-001 Development Program
- 
			
				.jpg) R&D R&DCelaid Therapeutics have executed a collaborative research agreement with AGC on Expansion and Functional Evaluation of iPSC-HSPCs